EGFR and cancer: In line with these findings, combined inhibition of EGFR and glycolysis has been shown to synergistically suppress proliferation of triple‐negative breast cancer cells (Lim et al., 2016), further supporting the relevance of EGFR signaling in cancer cell metabolism.